Excellent stuff @RitzyBusiness we are well and truly seeing the “drug commercialisation” phase happening before our eyes but market is valuing us almost in a drug discovery phase.
Once there are announcements for drug development updates market will become interested again, but once we officially hear news of solid steps to commercialisation such as any form of partnership I’m expecting some changes to our SP. When it happens might catch a few by surprise. DCB & team are firing on all cylinders.
DYOR….
RAC - RitzyBusiness' Investment Case - 8 June 2023, page-5
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.90 |
Change
0.015(0.80%) |
Mkt cap ! $317.6M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.93 | $1.85 | $160.5K | 85.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2049 | $1.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.91 | 1603 | 2 |
View Market Depth
| Last trade - 12.54pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |